BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21458719)

  • 1. Update on fungemia in oncology and hematology.
    Carreras E; Vázquez L; Rodríguez Tudela JL; Pahisa A; Azanza JR; Rovira M; de la Cámara R
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 4():42-7. PubMed ID: 21458719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on bacteraemia in oncology and hematology.
    Fortún J; Sanz MÁ; Madero L; López J; de la Torre J; Jarque I; Vallejo C
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 4():48-53. PubMed ID: 21458720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)].
    Böhme A; Ruhnke M; Karthaus M; Einsele H; Guth S; Heussel G; Heussel CP; Junghanss C; Kern WV; Kubin T; Sezer O; Silling G; Südhoff T; Szelényi H; Ullmann AJ;
    Dtsch Med Wochenschr; 2001 Dec; 126(50):1440-7. PubMed ID: 11743682
    [No Abstract]   [Full Text] [Related]  

  • 4. Fungal infections in neutropenic cancer patients.
    Parvez T
    J Coll Physicians Surg Pak; 2003 Nov; 13(11):669-73. PubMed ID: 14700501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the management of fungal infections.
    Muñoz P; Valerio M; Vena A; Bouza E; Posteraro B; Lass-Flörl C; Sanguinetti M
    Mycoses; 2015 Jun; 58 Suppl 2():1. PubMed ID: 26033250
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiological characteristics of fatal Candida krusei fungemia in immunocompromised febrile neutropenic children.
    Agirbasli H; Otlu B; Bilgen H; Durmaz R; Gedikoglu G
    Infection; 2008 Feb; 36(1):88-91. PubMed ID: 18084719
    [No Abstract]   [Full Text] [Related]  

  • 8. Empirical antifungal therapy in treating febrile neutropenic patients.
    Wingard JR
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
    Minari A; Hachem R; Raad I
    Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematology and oncology: recent advances in diagnosis and treatment].
    Heidemann E; Hiddemann W
    Dtsch Med Wochenschr; 2012 Oct; 137(42):2141. PubMed ID: 23055353
    [No Abstract]   [Full Text] [Related]  

  • 11. [Invasive mould disease in haematological patients].
    Ruiz-Camps I; Jarque I
    Rev Iberoam Micol; 2014; 31(4):249-54. PubMed ID: 25434346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida krusei fungemia in an immunocompromised patient.
    Hager JL; Mir MR; Hsu S
    Dermatol Online J; 2010 Apr; 16(4):5. PubMed ID: 20409412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on invasive mycoses by filamentous fungi in critically ill patients.
    Pemán J; Luque P; Nieto M; Pozo JC; Solé A; Zaragoza R
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 4():36-41. PubMed ID: 21458718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare yeasts causing fungemia in immunocompromised and haematology patients: Case series from Delhi.
    Capoor MR; Gupta DK; Verma PK; Sachdeva HC
    Indian J Med Microbiol; 2015; 33(4):576-9. PubMed ID: 26470968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management and prevention of invasive fungal infections in haematology].
    Wintenberger C
    Med Mal Infect; 2011 Sep; 41(9):503-7. PubMed ID: 21899968
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with liposomal amphotericin B at the Hematology-Oncology Department Children's Hospital Salata Medical School, University of Zagreb.
    Konja J; Glavas B; Anicić M
    Acta Biomed; 2006; 77 Suppl 2():14-6. PubMed ID: 16918061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?
    Sobel JD
    Crit Care Med; 2010 Mar; 38(3):990-2. PubMed ID: 20168159
    [No Abstract]   [Full Text] [Related]  

  • 20. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
    Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
    J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.